ProQR Therapeutics (PRQR) Change in Cash (2013 - 2026)
ProQR Therapeutics (PRQR) posted Change in Cash of -$13.6 million for Q1 2026, up 19.35% sequentially from -$16.9 million in Q4 2025, and up 21.77% YoY from -$11.2 million in Q1 2025.
ProQR Therapeutics (PRQR) Change in Cash (2013 - 2026) Analysis & Trends
ProQR Therapeutics has reported Change in Cash for 14 years, with the latest figure at -$13.6 million in Q1 2026.
- Quarterly Change in Cash rose 21.77% year-over-year to -$13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.8 million (down 216.95% YoY) and the FY2025 annual result came in at -$64.8 million, down 303.35% from the prior year.
- Change in Cash advanced to -$13.6 million in Q1 2026 per PRQR's latest filing, from -$16.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $63.4 million in Q4 2024 and troughed at -$59.9 million in Q3 2022.
- A 5-year average of -$7.3 million and a median of -$13.4 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash sank 431.09% in 2022, then soared 4264.73% in 2024.
- Over 5 years, Change in Cash stood at -$4.1 million in 2022, then surged by 63.18% to -$1.5 million in 2023, then jumped by 4264.73% to $63.4 million in 2024, then slumped by 126.61% to -$16.9 million in 2025, then gained by 19.35% to -$13.6 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$13.6 million, -$16.9 million, and -$15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | -13.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.60 Mn |
| Dec 31, 2025 | -16.86 Mn |
| Sep 30, 2025 | -15.02 Mn |
| Jun 30, 2025 | -13.35 Mn |
| Mar 31, 2025 | -17.38 Mn |
| Dec 31, 2024 | 63.36 Mn |
| Sep 30, 2024 | 11.65 Mn |
| Jun 30, 2024 | -7.33 Mn |
| Mar 31, 2024 | -36.16 Mn |
| Dec 31, 2023 | -1.52 Mn |
| Sep 30, 2023 | -8.85 Mn |
| Jun 30, 2023 | -12.29 Mn |
| Mar 31, 2023 | 47.63 Mn |
| Dec 31, 2022 | -4.13 Mn |
| Sep 30, 2022 | -59.86 Mn |
| Jun 30, 2022 | -16.47 Mn |
| Mar 31, 2022 | -23.85 Mn |
| Dec 31, 2021 | 34.96 Mn |
| Sep 30, 2021 | 18.08 Mn |
| Jun 30, 2021 | 88.29 Mn |